Shri Ahimsa Naturals FY26 PAT rises 37% to ₹30.08 crore

1 min read     Updated on 29 May 2026, 12:05 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Shri Ahimsa Naturals Limited reported a 37% YoY increase in PAT to ₹30.08 crore for FY26, with revenue rising 30% to ₹123.32 crore. The Board approved a ₹70 crore capex increase for its Sawarda plant expansion, integrating new processes to enhance operational capabilities.

powered bylight_fuzz_icon
41580078

*this image is generated using AI for illustrative purposes only.

Shri Ahimsa Naturals Limited reported a 37% year-on-year increase in Profit After Tax (PAT) to ₹30.08 crore for the financial year ended March 31, 2026, driven by robust volume growth. Revenue from operations rose 30% to ₹123.32 crore, while EBITDA increased 18% to ₹35.8 crore, maintaining a strong margin of 29.1% despite elevated freight costs. The company, a leading global manufacturer of natural caffeine, attributed the performance to a 20% volume growth in natural caffeine and improved realizations.

The balance sheet remained strong with low debt and sound liquidity. Operational efficiency improved as debtor days reduced to 86 days from 96 days in FY25, and inventory days decreased to 193 days from 214 days. Cash flow from operations stood at ₹12.22 crore during the period. The Board of Directors approved the audited standalone and consolidated financial results for the year ended March 31, 2026, along with the appointment of M/s Rajesh & Company as Cost Auditor and M/s Sharma, Singh & Mehta as Internal Auditor for FY26-27.

Financial Performance

The following table summarizes the financial performance for the fiscal years 2024, 2025, and 2026:

Fiscal Year Revenue (₹ in Crs) EBITDA (₹ in Crs) PAT (₹ in Crs) Natural Coffee Volume (in MTPA)
FY 2024 78 27 19 149
FY 2025 96 30 22 164
FY 2026 123.32 35.8 30.08 196

Expansion and Capex Plans

Shri Ahimsa Naturals is executing a greenfield expansion project at Sawarda, Jaipur, to scale manufacturing capabilities. The Board has approved the integration of additional facilities including a decaffeination process, Green Coffee Bean Extract (GCE) enrichment process, fungible botanical extraction process, and plant automation systems. These enhancements are expected to significantly improve operational capabilities and scalability.

The proposed upgrades entail an additional capital expenditure of up to ₹70 Crores. The funding structure includes ₹32.57 crore through preferential allotment of equity shares or warrants, ₹25 crore via bank term loan, and ₹12.43 crore from internal accruals. The new integrated facility is expected to commence operations by March 2027.

Current manufacturing capacity for natural caffeine stands at 270 MTPA, with capacity utilization at 72% in FY26, providing scope for incremental utilization to drive growth in FY27. The expansion strategy focuses on backward integration to ensure raw material security and cost competitiveness.

Historical Stock Returns for Shri Ahimsa Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.66%+3.97%+12.92%+13.92%+88.44%+105.10%

How will the company manage the increased leverage from the ₹25 crore term loan while maintaining its current low-debt status?

What is the projected revenue contribution from the new decaffeination and GCE enrichment facilities once they become operational by March 2027?

Will the capacity utilization rate improve significantly in FY27 before the new greenfield facility comes online?

Shri Ahimsa Naturals Allots 3,77,600 Equity Shares at ₹227 Each Upon Warrant Conversion

2 min read     Updated on 13 May 2026, 11:12 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Shri Ahimsa Naturals Limited allotted 3,77,600 fully paid-up equity shares at ₹227 each upon conversion of convertible warrants originally issued on January 13, 2026, collecting ₹6,42,86,400 as the balance 75% warrant price. The preferential allotment was made to four investors — two promoters and two non-promoters — increasing the company's paid-up capital from ₹23,43,09,000 to ₹23,80,85,000, as disclosed under Regulation 30 of the SEBI Listing Regulations.

powered bylight_fuzz_icon
40196471

*this image is generated using AI for illustrative purposes only.

Shri Ahimsa Naturals Limited's Board of Directors, at its meeting held on Tuesday, May 12, 2026, approved the allotment of 3,77,600 (Three Lakhs Seventy Seven Thousand Six Hundred) fully paid-up equity shares of face value ₹10/- each at an issue price of ₹227/- per share (including a premium of ₹217/- per share). The allotment was made pursuant to the conversion of an equivalent number of convertible warrants, following receipt of the balance 75% of the warrant issue price from the respective warrant holders. This development was disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was in furtherance to the approval granted by members at the Extra-Ordinary General Meeting held on November 26, 2025.

Warrant Conversion and Allotment Details

The warrants were originally allotted on January 13, 2026, at a price of ₹227/- each, with 25% of the issue price received at the time of subscription. The balance 75% was received from the warrant holders prior to the current allotment. The total amount received towards the 75% balance across all allottees aggregated to ₹6,42,86,400. The following table summarises the allotment details for each warrant holder:

Warrant Holder: Amount Received Towards 75% (₹) No. of Warrants Eligible for Conversion No. of Equity Shares Allotted
Nemi Chand Jain 1,90,68,000 1,12,000 1,12,000
Amit Kumar Jain 1,90,68,000 1,12,000 1,12,000
NKA Resources LLP 2,24,73,000 1,32,000 1,32,000
Sajal Family Trust 36,77,400 21,600 21,600
Total 6,42,86,400 3,77,600 3,77,600

Investor Categories and Shareholding Impact

The allotment was made to four investors — two classified as promoters (Nemi Chand Jain and Amit Kumar Jain) and two as non-promoters (NKA Resources LLP and Sajal Family Trust). The issuance was carried out as a preferential allotment in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws. The table below presents the pre- and post-allotment equity holding positions for each allottee:

Allottee: Pre-Issue Shares Pre-Issue Holding (%) Shares Allotted Post-Issue Shares Post-Issue Holding (%)
Nemi Chand Jain 64,05,700 27.34 1,12,000 65,17,700 27.38
Amit Kumar Jain 39,02,500 16.66 1,12,000 40,14,500 16.86
NKA Resources LLP Nil - 1,32,000 1,32,000 0.55
Sajal Family Trust Nil - 21,600 21,600 0.09
Total 1,03,08,200 44 3,77,600 1,06,85,800 44.88

Impact on Paid-Up Capital

Subsequent to the allotment, the issued, subscribed, and paid-up capital of Shri Ahimsa Naturals has increased as detailed below:

Parameter: Before Allotment After Allotment
Number of Equity Shares 2,34,30,900 2,38,08,500
Face Value per Share ₹10/- ₹10/-
Aggregate Paid-Up Capital ₹23,43,09,000/- ₹23,80,85,000/-

The newly allotted equity shares rank pari-passu with the existing equity shares of the company in all respects. The Board meeting commenced at 5:00 PM and concluded at 6:45 PM on May 12, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.

Historical Stock Returns for Shri Ahimsa Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.66%+3.97%+12.92%+13.92%+88.44%+105.10%

How might the increased promoter shareholding to ~44.88% influence Shri Ahimsa Naturals' corporate governance decisions and minority shareholder rights going forward?

What strategic initiatives or capital deployment plans does Shri Ahimsa Naturals intend to fund with the ₹8.57 crore raised through the full warrant conversion cycle?

Could the entry of new non-promoter investors like NKA Resources LLP signal potential future strategic partnerships or further preferential allotments for Shri Ahimsa Naturals?

More News on Shri Ahimsa Naturals

1 Year Returns:+88.44%